1Satta MA, Nanni S, Della Casa S, et al. Molecular biology of thyroid neoplasms. Rays, 2000,25: 151-161.
2Kroll TG, Sarraf P, Pecciarini L, et al. PAX8-PPAR γ1 fusion oncogene in human thyroid carcinoma. Science, 2002,289: 1357-1360.
3Demetri GD,Fletcher CD,Mueller E,et al. Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-γ ligand troglitazone in patients with liposarcoma. Proc Natl Acad Sci U S A, 1999,96: 3951-3956.
4Gustafson KS, LiVolsi VA, Furth EE, et al. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies. Am J Clin Pathol, 2003,120: 175-181.
5Puglisi F, Cesselli D, Damante G, et al. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases. Anticancer Res, 2000,20: 311-316.
6Lui WO, Kytola S, Anfalk L, et al. Balanced translocation (3;7)(p25;q34): another mechanism of tumorigenesis in follicular thyroid carcinoma? Cancer Genet Cytogenet, 2000,119: 109-112.
7Roque L, Clode A, Belge G, et al. Follicular thyroid carcinoma: chromosome analysis of 19 cases. Genes Chromosomes Cancer, 1998,21: 250-255.
8Kitamura Y, Shimizu K, Ito K, et al. Allelotyping of follicular thyroid carcinoma: frequent allelic losses in chromosome arms 7q, 11p, and 22q. J Clin Endocrinol Metab, 2001,86: 4268-4272.
9Wynford-Thomas D. Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms. Horm Res, 1997,47: 145-157.
10Liu G, Takano T, Matsuzuka F, et al. Screening of specific changes in mRNAs in thyroid tumors by sequence specific differential display: decreased expression of c-fos mRNA in papillary carcinoma. Endocr J, 1999,46: 459-466.
8Renshaw AA, Gould EW. Why there is the tendency to " overdiagnose " the follicular variant of papillary thyroid carcinoma. Am J Clin Pathol, 2002, 117( 1 ) :19-21.
9Cerutti JM, Delceio R, Amadei M J, ct al. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest, 2004, 113 ( 8 ) : 1234-1242.
10Beesley MF, Mclaren KM. Cytokeratin 19 and galectin-3 immunohistochemisty in the differential diagnosis of solitary thyroid nodules. Histopathology, 2002, 41 (3) : 236-243.
